This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Foundation Medicine, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Erica Gornstein and Cancer-Related Patent Innovation.
Introduction
Erica Gornstein is an inventor associated with Foundation Medicine, Inc., in Cambridge, Massachusetts. Her patent work concerns NTRK fusion molecules and their potential applications in cancer evaluation and treatment.
Latest Patents
The provided information identifies one patent associated with Gornstein: “NTRK Fusion Molecules and Uses Thereof.” The patent describes NTRK fusion molecules and detection reagents, along with methods and kits for evaluating, identifying, or assessing a subject with cancer and supporting treatment decisions. The supplied data lists 1 patent.
Career Highlights
Gornstein’s listed invention focuses on tools and methods related to identifying and assessing cancers involving NTRK fusions. This work is associated with Foundation Medicine, Inc., a company working in the field of cancer diagnostics.
Collaborations
The provided information names Christopher Darcy and Anthony Classon as Gornstein’s coworkers. Their inclusion reflects professional connections associated with her work at Foundation Medicine, Inc.
Conclusion
Erica Gornstein’s listed patent centers on NTRK fusion molecules and diagnostic applications that may inform cancer assessment and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile